NHS National Pharmaceuticals Transition 2022_2
key details
| Value | £267,740,679 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 23 Aug 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-03538e |
Awards (36)
This procurement was awarded to 18 suppliers. Values shown are per-award; the notice total is £267,740,679.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Accord-UK Ltd shared | · | · | active |
| Amarox Limited shared | £35,745,737 | 1 Nov 2022 | active |
| Amarox Limited shared | · | · | active |
| Ascend Laboratories UK Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Ascend Laboratories UK Ltd shared | · | · | active |
| Aspire Pharma Limited shared | £35,745,737 | 1 Nov 2022 | active |
| Aspire Pharma Limited shared | · | · | active |
| Cipla shared | £35,745,737 | 1 Nov 2022 | active |
| Cipla shared | · | · | active |
| Colonis Pharma Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Colonis Pharma Ltd shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £35,745,737 | 1 Nov 2022 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Gerot Lannach UK Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Gerot Lannach UK Ltd shared | · | · | active |
| Glenmark Pharmaceuticals Europe Limited shared | £35,745,737 | 1 Nov 2022 | active |
| Glenmark Pharmaceuticals Europe Limited shared | · | · | active |
| Milpharm Ltd/aurobinbdo shared | £35,745,737 | 1 Nov 2022 | active |
| Milpharm Ltd/aurobinbdo shared | · | · | active |
| Morningside Pharmaeuticals shared | £35,745,737 | 1 Nov 2022 | active |
| Morningside Pharmaeuticals shared | · | · | active |
| Mylan shared | £35,745,737 | 1 Nov 2022 | active |
| Mylan shared | · | · | active |
| Pfizer Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Pfizer Ltd shared | · | · | active |
| Selective Supplies Ltd. shared | £35,745,737 | 1 Nov 2022 | active |
| Selective Supplies Ltd. shared | · | · | active |
| Takeda UK Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Takeda UK Ltd shared | · | · | active |
| Teva UK Limited shared | £35,745,737 | 1 Nov 2022 | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | £35,745,737 | 1 Nov 2022 | active |
| Thornton and Ross Ltd shared | · | · | active |
| Wockhardt UK Limited shared | £35,745,737 | 1 Nov 2022 | active |
| Wockhardt UK Limited shared | · | · | active |
description
Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months)
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Iviq/rYRrBntgVTzsywqejDFpoU7YZuUNlW8eaTBv1JP0P_o
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivir/VS.kZqx3GQmsc9vSW5vfGqiCuf55ZUymhlEUIk6kGFY
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivis/u4_DrX6okTHLwodKdhWtBHw2vSPX1WsTRKdZE32_U84
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj0/QeRR85j55pkxrCWvUQLvCMRNleepwbMxypEKgjOpGzE
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj1/frO_kGKP7ZsRleNjyWVG.TmWbqjikFdCuFr34ZMzyX4
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj2/YkgGZhKKh3HMeAv2.qk7J5doGJtRYTIpEdsm7wdBNJ0
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj3/7Ee5Trmm5oIfqSu8SeB4vCdvaFvF1gzseKwADZGLGC4
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj4/qgajUgplVAri9bToYF9u6uf0TEPHe8PQkkDu.daZx3Q
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivje/cHqIuNUcp2PZUW6Z17qF85YJhES3UVQqZCd9ZFs1oVo
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjF/B6uuKf5UqznqkGnp9W1GOrRAyer7ZV0qbTGoYGvaBw0
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjG/yEaNfC5Y6JwDSPjWoCRRiZ.HCBL80FgO_RTOO5WIyqQ
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjP/yrDUAf0S1YBEin_pG46sQ.Nf95rxSyHTwfUxW_PpMjI
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjQ/yqwBlJKTpyFKBhYtXzgWysBAYKyhDfcPzKiWYCekqLE
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjZ/xVpEfJRGUjri3drUYVY71cmSaNcqLbr1XKKUfrp22GU
- https://www.contractsfinder.service.gov.uk/Notice/26487991-3c18-4fae-9686-311c8f48460e , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 8 Jul 2022 | Planning (planning) | · | af121852-1005-401f-9a5b-a30830caec6e-553130 |
| 19 Jul 2022 | Contract notice (F02) | Earlier regulations | 019686-2022 |
| 19 Jul 2022 | Tender (tender) | · | 26487991-3c18-4fae-9686-311c8f48460e-555872 |
| 26 Jul 2022 | Corrigendum (F14) | Earlier regulations | 020378-2022 |
| 4 Nov 2022 | Contract award notice (F03) | Earlier regulations | 031197-2022 |
| 4 Nov 2022 | Award (award) | · | ce6948d4-7624-4e72-b9a5-a306a51c8142-586807 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.